Zoledronic Acid Benefit in Breast Cancer: Data Published in NEJM

A study in the New England Journal of is one of the first to show that a bisphosphonate used for osteoporosis and bone metastases also has a benefit in breast .
Medscape Medical News


Read more

Related posts

Leave a Reply